Related Experiment Video
Updated: Sep 2, 2025

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter
Published on: August 12, 2021
Prevalence of anti-SARS-CoV-2 antibody in hemodialysis facilities: a cross-sectional multicenter study from Madinah
Abdulrahman A Housawi1, Shazada Junaid S Qazi2, Abdulhalem A Jan3
1From the Ministry of Health, Riyadh, Saudi Arabia.
Insights
Hemodialysis patients and staff showed high SARS-CoV-2 IgG antibody prevalence, suggesting widespread prior infection, including asymptomatic cases. Immunity varied by dialysis center, indicating localized transmission dynamics.
Area of Science:
- Infectious Diseases
- Immunology
- Nephrology
Background:
- Coronavirus disease 2019 (COVID-19) has spread globally, impacting vulnerable populations like hemodialysis patients.
- Hemodialysis patients are at increased risk due to frequent healthcare interactions and potential immunocompromise.
Purpose of the Study:
- To compare the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity between hemodialysis patients and healthcare staff.
- To identify factors associated with SARS-CoV-2 seropositivity in this population.
Main Methods:
- A cross-sectional study with prospective follow-up was conducted in hemodialysis centers in the Madinah region.
- 830 participants (677 patients, 153 staff) were tested for SARS-CoV-2 immunoglobulin G (IgG) antibodies.
- Factors influencing seropositivity, including history of COVID-19 and symptoms, were analyzed.
Main Results:
- Overall SARS-CoV-2 IgG antibody prevalence was 38.0% in patients and 44.4% in staff (P=.1379).
- A history of COVID-19 or related symptoms significantly increased the likelihood of being IgG positive (P<.0001).
- Seropositivity demonstrated a center-dependent pattern, suggesting localized transmission.
Conclusions:
- High antibody prevalence in hemodialysis patients and staff indicates significant past SARS-CoV-2 infection, including asymptomatic cases.
- The center-dependent immunity suggests that infection control and transmission dynamics vary across different healthcare settings.
- Further investigation is needed to understand the implications for infection control in hemodialysis units.
Background:
Since the occurrence of coronavirus disease in 2019 (COVID-19), the global community has witnessed its exponential spread with devastating outcomes within the general population and specifically within hemodialysis patients.
Objectives:
Compare the state of immunity to SARS-CoV-2 among hemodialysis patients and staff.
Design:
Cross-sectional study with a prospective follow-up period.
Setting:
Hemodialysis centers in Madinah region.
Patients And Methods:
We prospectively tested for SARS-CoV-2 antibodies in dialysis patients using dialysis centers staff as controls. The participants were tested on four occasions when feasible for the presence of anti-SARS-CoV-2 antibodies. We also analyzed factors that might be associated with seropositivity.
Main Outcome Measures:
SARS-CoV-2 positivity using immunoglobulin G (IgG) levels SAMPLE SIZE: 830 participants, 677 patients and 153 dialysis centers staff as controls.
Results:
Of the total participants, 325 (257 patients and 68 staff) were positive for SARS-CoV-2 IgG antibodies, for a prevalence of 38.0% and 44.4% among patients and staff, respectively (P=.1379). Participants with a history of COVID-19 or related symptoms were more likely to have positive IgG (P<.0001). Surprisingly, positivity was also center-dependent. In a multivariable logistic regression, a history of infection and related symptoms contributed significantly to developing immunity.
Conclusion:
The high prevalence of SARS-CoV-2 antibody among hemodialysis patients and previously asymptomatic staff suggested past asymptomatic infection. Some centers showed more immunity effects than others.
Limitations:
Unable to collect four samples for each participant; limited to one urban center.
Conflict Of Interest:
None.
More Related Videos
10:25Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
07:08A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System
Published on: April 6, 2021
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Hemodialysis III: Nursing Management